Udhane, V.; Larson, A.; Adams, J.N.; Jagadish, R.; Acevedo, A.; Domagala, B.A.; Vo, S.A.; Peltier, T.; Sanchez, D.; Keo, V.;
et al. Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System Cancers. Diagnostics 2026, 16, 851.
https://doi.org/10.3390/diagnostics16060851
AMA Style
Udhane V, Larson A, Adams JN, Jagadish R, Acevedo A, Domagala BA, Vo SA, Peltier T, Sanchez D, Keo V,
et al. Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System Cancers. Diagnostics. 2026; 16(6):851.
https://doi.org/10.3390/diagnostics16060851
Chicago/Turabian Style
Udhane, Vindhya, Alexandra Larson, Jennifer N. Adams, Rakshitha Jagadish, Anthony Acevedo, Brett A. Domagala, Samantha A. Vo, Tarin Peltier, Daniel Sanchez, Viriya Keo,
and et al. 2026. "Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System Cancers" Diagnostics 16, no. 6: 851.
https://doi.org/10.3390/diagnostics16060851
APA Style
Udhane, V., Larson, A., Adams, J. N., Jagadish, R., Acevedo, A., Domagala, B. A., Vo, S. A., Peltier, T., Sanchez, D., Keo, V., Ernst, J., Schilter, K. F., Nie, Q., & Reddi, H. V.
(2026). Variant Allelic Frequency to Track Therapy Response and Evaluate Leptomeningeal Disease in Metastatic Central Nervous System Cancers. Diagnostics, 16(6), 851.
https://doi.org/10.3390/diagnostics16060851